Charles Schwab
VIVE

Charles Schwab’s VIVEVE MED INC VIVE Stock Holding History

Charles Schwab’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-26
Closed -$96K – 3164
2018
Q1 		$96K Hold
26
– – ﹤0.01% 3043
2017
Q4 		$131K Hold
26
– – ﹤0.01% 3020
2017
Q3 		$138K Hold
26
– – ﹤0.01% 3050
2017
Q2 		$189K Buy
+26
New +$194K ﹤0.01% 3037

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Charles Schwab's VIVE Position: Q2 2018 in Review

Charles Schwab sold out of VIVEVE MED INC (VIVE) in Q2 2018, closing a stake of 26 shares — an estimated $96K sold.

Charles Schwab first reported a position in VIVE in Q2 2017 and held it in 4 quarters. The position peaked at $189K in Q2 2017. 46 funds tracked by Wall St. Rank hold VIVE as of Q2 2018.

  • Charles Schwab reported no remaining VIVEVE MED INC position as of Q2 2018 after selling out during the quarter.
  • Charles Schwab sold 26 VIVEVE MED INC shares in Q2 2018, an estimated $96K.
  • Charles Schwab first reported a position in VIVEVE MED INC in Q2 2017 and held it in 4 quarters.
  • Charles Schwab's VIVEVE MED INC position peaked at $189K in Q2 2017.
  • 46 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2018.

Based on Charles Schwab's 13F filing for Q2 2018, filed 8 Aug 2018.